These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 10666618)
21. A new type of aspartic proteinase inhibitors with a symmetric structure. Tarasova NI; Gulnik SV; Prischenko AA; Livantsov MV; Lysogorskaya EN; Oksenoit ES Adv Exp Med Biol; 1991; 306():539-42. PubMed ID: 1812755 [No Abstract] [Full Text] [Related]
22. Thermodynamic mapping of the inhibitor site of the aspartic protease endothiapepsin. Gómez J; Freire E J Mol Biol; 1995 Sep; 252(3):337-50. PubMed ID: 7563055 [TBL] [Abstract][Full Text] [Related]
23. High-resolution X-ray diffraction study of the complex between endothiapepsin and an oligopeptide inhibitor: the analysis of the inhibitor binding and description of the rigid body shift in the enzyme. Sali A; Veerapandian B; Cooper JB; Foundling SI; Hoover DJ; Blundell TL EMBO J; 1989 Aug; 8(8):2179-88. PubMed ID: 2676515 [TBL] [Abstract][Full Text] [Related]
24. Crystal structure of aspartic proteinase from Irpex lacteus in complex with inhibitor pepstatin. Fujimoto Z; Fujii Y; Kaneko S; Kobayashi H; Mizuno H J Mol Biol; 2004 Aug; 341(5):1227-35. PubMed ID: 15321718 [TBL] [Abstract][Full Text] [Related]
25. Design and Synthesis of Bioisosteres of Acylhydrazones as Stable Inhibitors of the Aspartic Protease Endothiapepsin. Jumde VR; Mondal M; Gierse RM; Unver MY; Magari F; van Lier RCW; Heine A; Klebe G; Hirsch AKH ChemMedChem; 2018 Nov; 13(21):2266-2270. PubMed ID: 30178575 [TBL] [Abstract][Full Text] [Related]
26. High resolution X-ray analyses of renin inhibitor-aspartic proteinase complexes. Foundling SI; Cooper J; Watson FE; Cleasby A; Pearl LH; Sibanda BL; Hemmings A; Wood SP; Blundell TL; Valler MJ Nature; 1987 May 28-Jun 3; 327(6120):349-52. PubMed ID: 3295561 [TBL] [Abstract][Full Text] [Related]
27. The three-dimensional structure at 2.4 A resolution of glycosylated proteinase A from the lysosome-like vacuole of Saccharomyces cerevisiae. Aguilar CF; Cronin NB; Badasso M; Dreyer T; Newman MP; Cooper JB; Hoover DJ; Wood SP; Johnson MS; Blundell TL J Mol Biol; 1997 Apr; 267(4):899-915. PubMed ID: 9135120 [TBL] [Abstract][Full Text] [Related]
28. Adaptation of the behaviour of an aspartic proteinase inhibitor by relocation of a lysine residue by one helical turn. Winterburn TJ; Wyatt DM; Phylip LH; Berry C; Bur D; Kay J Biol Chem; 2006 Aug; 387(8):1139-42. PubMed ID: 16895485 [TBL] [Abstract][Full Text] [Related]
29. A preliminary neutron crystallographic study of proteinase K at pD 6.5. Gardberg AS; Blakeley MP; Myles DA Acta Crystallogr Sect F Struct Biol Cryst Commun; 2009 Feb; 65(Pt 2):184-7. PubMed ID: 19194016 [TBL] [Abstract][Full Text] [Related]
30. Lowering the entropic barrier for binding conformationally flexible inhibitors to enzymes. Khan AR; Parrish JC; Fraser ME; Smith WW; Bartlett PA; James MN Biochemistry; 1998 Dec; 37(48):16839-45. PubMed ID: 9836576 [TBL] [Abstract][Full Text] [Related]
31. An unusual orientation for Tyr75 in the active site of the aspartic proteinase from Saccharomyces cerevisiae. Gustchina A; Li M; Phylip LH; Lees WE; Kay J; Wlodawer A Biochem Biophys Res Commun; 2002 Jul; 295(4):1020-6. PubMed ID: 12127998 [TBL] [Abstract][Full Text] [Related]
32. A history of neutrons in biology: the development of neutron protein crystallography at BNL and LANL. Schoenborn BP Acta Crystallogr D Biol Crystallogr; 2010 Nov; 66(Pt 11):1262-8. PubMed ID: 21041948 [TBL] [Abstract][Full Text] [Related]
33. Aspartic proteinases in disease: a structural perspective. Cooper JB Curr Drug Targets; 2002 Apr; 3(2):155-73. PubMed ID: 11958298 [TBL] [Abstract][Full Text] [Related]
34. Binding of phosphinate and phosphonate inhibitors to aspartic proteases: a first-principles study. Vidossich P; Carloni P J Phys Chem B; 2006 Jan; 110(3):1437-42. PubMed ID: 16471695 [TBL] [Abstract][Full Text] [Related]
35. Experimental Active-Site Mapping by Fragments: Hot Spots Remote from the Catalytic Center of Endothiapepsin. Radeva N; Krimmer SG; Stieler M; Fu K; Wang X; Ehrmann FR; Metz A; Huschmann FU; Weiss MS; Mueller U; Schiebel J; Heine A; Klebe G J Med Chem; 2016 Aug; 59(16):7561-75. PubMed ID: 27463859 [TBL] [Abstract][Full Text] [Related]
37. The structure of endothiapepsin complexed with the gem-diol inhibitor PD-135,040 at 1.37 A. Coates L; Erskine PT; Mall S; Williams PA; Gill RS; Wood SP; Cooper JB Acta Crystallogr D Biol Crystallogr; 2003 Jun; 59(Pt 6):978-81. PubMed ID: 12777758 [TBL] [Abstract][Full Text] [Related]
38. X-ray analyses of aspartic proteinases. V. Structure and refinement at 2.0 A resolution of the aspartic proteinase from Mucor pusillus. Newman M; Watson F; Roychowdhury P; Jones H; Badasso M; Cleasby A; Wood SP; Tickle IJ; Blundell TL J Mol Biol; 1993 Mar; 230(1):260-83. PubMed ID: 8450540 [TBL] [Abstract][Full Text] [Related]
39. Crystallographic studies of reduced bond inhibitors complexed with an aspartic proteinase. Foundling SI; Cooper J; Watson FE; Pearl LH; Hemmings A; Wood SP; Blundell T; Hallett A; Jones DM; Sueiras J J Cardiovasc Pharmacol; 1987; 10 Suppl 7():S59-68. PubMed ID: 2485065 [TBL] [Abstract][Full Text] [Related]
40. High-resolution neutron protein crystallography with radically small crystal volumes: application of perdeuteration to human aldose reductase. Hazemann I; Dauvergne MT; Blakeley MP; Meilleur F; Haertlein M; Van Dorsselaer A; Mitschler A; Myles DA; Podjarny A Acta Crystallogr D Biol Crystallogr; 2005 Oct; 61(Pt 10):1413-7. PubMed ID: 16204895 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]